The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects
10.1111/j.1365-2125.2008.03184.x
Saved in:
Main Authors: | Adkison, K.K., Vaidya, S.S., Mehta, A.A., Lee, D.Y., Polli, J.W., Lou, Y., Koo, S.H., Li, L., Lee, E.J.D., Gross, A.S. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/27291 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration
by: Adkison, K.K., et al.
Published: (2011) -
Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration
by: Adkison, K.K., et al.
Published: (2016) -
Characterization of a side population of astrocytoma cells in response to temozolomide: Laboratory investigation
by: Chua, C., et al.
Published: (2014) -
Clinical pharmacology and pharmacogenetics of gemcitabine
by: Wong, A., et al.
Published: (2014) -
Investigations on aurones as modulators of ABCG2
by: SIM HONG MAY
Published: (2010)